Abiopharma

News list

Hudson Derek 🟡 adjusted position in 3.4K shares of ATN International, Inc. (ATNI) at $27.15 Transaction Date: Jun 16, 2026 | Filing ID: 000002

Full text

News bot June 18, 2026, 5:34 p.m.
🔍 Hudson Derek (Executive)

Company: ATN International, Inc. (ATNI)

Report Date: 2026-06-16
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 4,788
- Total shares sold: 1,436
Detailed Transactions and Holdings:
- Acquired 4,788 shares of Common Stock at $27.15 per share (Direct)
  Date: 2026-06-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 17,157.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 1,436 shares of Common Stock at $27.15 per share (Direct)
  Date: 2026-06-16 | Code: F | equity_swap_involved: 0 | shares_owned_after: 15,721.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents fully vested shares of restricted stock grant pursuant to the Issuer's 2023 Equity Incentive Plan in payment of Mr. Hudson's 2026 annual director retainer based on the moving average price for the past twenty days of $27.15 of the Issuer's common stock as of June 12, 2026.
- F2: Represents shares withheld by the Company for payment of Mr. Hudson's tax obligations.